iniparib BSI

Related by string. * : iniparib / BSi . BSIs : backside illumination BSI . TASE BSI . NYSE BSI hereinafter . BSI Inspectorate . BSI CMOS sensor . Standards Institution BSI . BSI Kitemark . Special Investigations BSI . BSI PAS . CR BSI . BSI CMOS . BSI * *

Related by context. Frequent words. (Click for all words.) 65 chemoradiotherapy 65 XELOX 65 DOXIL 65 Amrubicin 65 mg kg dose 64 RECIST criteria 64 mycophenolate mofetil 64 patients evaluable 63 HER2 positive metastatic breast 63 Navelbine 63 Fludara 63 plus dexamethasone 63 metastatic hormone refractory 63 pertuzumab 62 abiraterone acetate 62 TORISEL 62 nab paclitaxel 62 Mylotarg 62 decitabine 62 FOLFIRI 62 evaluable patients 62 malignant pleural mesothelioma 62 PRECiSE 61 neoadjuvant therapy 61 Hycamtin 61 relapsed refractory multiple myeloma 61 interferon alfa 61 cabazitaxel 61 distant metastasis 61 Jevtana 61 Taxotere ® 61 Irinotecan 61 mg BID 61 fluorouracil 61 elotuzumab 61 plus gemcitabine 61 neoadjuvant chemotherapy 61 topotecan 61 tamoxifen therapy 61 GVAX 61 tesmilifene 61 relapsed multiple myeloma 60 active comparator 60 plus prednisone 60 dose escalation 60 Median survival 60 heavily pretreated 60 ADXS# 60 Torisel 60 neoadjuvant 60 glargine 60 Arch Intern Med 60 androgen deprivation 60 metastatic renal cell carcinoma 60 FOLFOX 59 sustained virologic response 59 SUTENT 59 placebo controlled clinical 59 Bevacizumab 59 OPAXIO 59 temsirolimus 59 mg QD 59 HGS ETR1 59 vinorelbine 59 liver transplant recipients 59 custirsen 59 Erlotinib 59 chemoradiation 59 epithelial ovarian cancer 59 KRAS mutations 59 aflibercept 59 mitoxantrone 59 dasatinib 59 breast carcinoma 59 adecatumumab 59 gastrointestinal stromal tumors 59 cytogenetic response 59 VIDAZA 59 pemetrexed 59 interferon beta 1a 59 adjuvant chemotherapy 59 Azedra 58 superficial bladder cancer 58 Phase Ib clinical 58 refractory multiple myeloma 58 bone metastasis 58 sunitinib 58 irbesartan 58 axitinib 58 low dose dexamethasone 58 IMC A# 58 eribulin 58 peginterferon alfa 2b 58 pheochromocytoma 58 patients undergoing chemotherapy 58 dacarbazine 58 pazopanib 58 double blinded placebo 58 tanespimycin 58 INGN 58 luteinizing hormone releasing

Back to home page